This dose was selected based on established literature demonstrating its effectiveness in reliably inducing status epilepticus without causing excessive mortality in mice.[18] We assessed the severity of seizures using the modified Racine Scale[19] and observed that DEC2 KD mice exhibited an accelerated progression of seizures, indicated by the higher maximum seizure class they reached in each 10‐min interval as compared to the control mice within the 90‐min observation period (Figure 2D). The gene discussed is BHLHE41; the disease is status epilepticus.